Key Highlights

  • Shares traded at $127.71 in today's intraday trading, up 0.05%.
  • Covista completed its rebranding from Adtalem Global Education and changed its ticker to CVSA in early 2026.
  • The company outlined a multi-year growth strategy with long-term financial targets extending toward the end of the decade.
  • For fiscal 2026, Revenue is expected to grow in the mid-to-high single digits toward roughly $1.9 billion.

Covista (NYSE:CVSA) is a for-profit education company focused on healthcare, describing itself as a leading educator of healthcare professionals in the United States. Shares traded at $127.71 in today's intraday trading, up 0.05%.

Formerly known as Adtalem Global Education, it rebranded to Covista and changed its ticker in early 2026, operating institutions that educate large numbers of nursing, medical, and other healthcare students.

Latest Developments

Covista completed its rebranding from Adtalem Global Education and changed its ticker to CVSA in early 2026, and it has outlined a multi-year growth strategy with long-term financial targets extending toward the end of the decade. For fiscal 2026, the company has pointed to revenue growth in the mid-to-high single digits, reaching roughly $1.9 billion, with adjusted Earnings Per Share growth in the high teens to around twenty percent. Investors should confirm the latest enrollment trends, revenue and its growth, and guidance and long-term targets directly from SEC filings.

Financial and Business Position

Covista's Investment case rests on persistent Demand for healthcare workers driving demand for its healthcare-focused education, its enrollment and tuition revenue, and its margins and earnings growth, balanced against regulatory oversight of for-profit education. Investors should watch enrollment trends across its institutions and operating margins.

Stock-Market Context

CVSA shares traded at $127.71 in today's intraday trading, up 0.05%. The stock trades as a for-profit healthcare-education company whose valuation reflects its enrollment and earnings growth and the demand backdrop from healthcare-workforce shortages.

What Investors Should Watch

Watch enrollment trends across its institutions, revenue and its growth, operating margins, adjusted earnings per share and its growth, and progress against its long-term targets. Continued enrollment and revenue growth combined with Margin and earnings expansion would be the most likely factors to put it on more watchlists.